For life sciences companies based outside the US, contemplating entrance into that vital market can seem exciting and challenging in equal measures. There are a variety of business, financial, and legal factors to be considered which include:

- Engagement with US investors

- How and when to IPO

- Building a workforce

- Accessing licensing partners for potential collaborations

- Mergers and acquisitions as part of the commercial process.

- This panel hosted by Mintz and Mills & Reeve, will address each of the aforementioned and more - while focusing on the current economic environment.

Panelists:

Moderator, William Hicks, Co-Chair, Life Sciences Practice, Mintz (William C. Hicks | Member / Co-chair, Securities & Capital Markets | Mintz)

Michael Jiang, Senior Managing Director in the Equity Capital Markets, Guggenheim Securities (60) Michael Jiang | LinkedIn)

US Investor TBD

Michael Chen, CEO, Nuclera

Agenda:

8:30 am to 9:00 am: Registration/breakfast

9:00 am to 10:00 am: Program

10:00 am to 11:00 am: Networking

Registration:

Attendance at this event is free of charge and by invitation only.

To request an invitation, please email Tony Jones, One Nucleus, at your earliest convenience on tony@onenucleus.com.